Logo image of IVVD

INVIVYD INC (IVVD) Stock Price, Quote, News and Overview

NASDAQ:IVVD - Nasdaq - US00534A1025 - Common Stock - Currency: USD

1.21  -0.19 (-13.57%)

Premarket: 1.29 +0.08 (+6.61%)

IVVD Quote, Performance and Key Statistics

INVIVYD INC

NASDAQ:IVVD (2/20/2025, 8:00:01 PM)

Premarket: 1.29 +0.08 (+6.61%)

1.21

-0.19 (-13.57%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High4.74
52 Week Low0.35
Market Cap144.74M
Shares119.62M
Float96.19M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE10.47
Earnings (Next)03-26 2025-03-26/amc
IPO08-06 2021-08-06


IVVD short term performance overview.The bars show the price performance of IVVD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150

IVVD long term performance overview.The bars show the price performance of IVVD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of IVVD is 1.21 USD. In the past month the price increased by 197.59%. In the past year, price decreased by -71.99%.

INVIVYD INC / IVVD Daily stock chart

IVVD Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.85 354.98B
AMGN AMGEN INC 15.03 159.99B
GILD GILEAD SCIENCES INC 23.87 137.10B
VRTX VERTEX PHARMACEUTICALS INC 1656.31 123.40B
REGN REGENERON PHARMACEUTICALS 15.25 76.09B
ARGX ARGENX SE - ADR N/A 39.34B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.37B
BNTX BIONTECH SE-ADR N/A 28.26B
ONC BEIGENE LTD-ADR N/A 26.06B
NTRA NATERA INC N/A 22.20B
BIIB BIOGEN INC 8.32 19.98B
SMMT SUMMIT THERAPEUTICS INC N/A 17.01B

About IVVD

Company Profile

IVVD logo image Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is headquartered in Waltham, Massachusetts and currently employs 94 full-time employees. The company went IPO on 2021-08-06. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The firm delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2 (COVID-19). Its PEMGARDA is the Company’s first mAb in a planned series of innovative mAb candidates designed to keep pace with SARS-CoV-2 viral evolution. Its VYD2311 is optimized for neutralization potency against recent SARS-CoV-2 lineages such as BA.2.86 and JN.1. The firm also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.

Company Info

INVIVYD INC

1601 Trapelo Road, Suite 178

Waltham MASSACHUSETTS US

Employees: 95

Company Website: https://invivyd.com/

Investor Relations: https://investors.invivyd.com/

Phone: 17818190080

INVIVYD INC / IVVD FAQ

What is the stock price of INVIVYD INC today?

The current stock price of IVVD is 1.21 USD. The price decreased by -13.57% in the last trading session.


What is the ticker symbol for INVIVYD INC stock?

The exchange symbol of INVIVYD INC is IVVD and it is listed on the Nasdaq exchange.


On which exchange is IVVD stock listed?

IVVD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INVIVYD INC stock?

9 analysts have analysed IVVD and the average price target is 6.01 USD. This implies a price increase of 396.3% is expected in the next year compared to the current price of 1.21. Check the INVIVYD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INVIVYD INC worth?

INVIVYD INC (IVVD) has a market capitalization of 144.74M USD. This makes IVVD a Micro Cap stock.


How many employees does INVIVYD INC have?

INVIVYD INC (IVVD) currently has 95 employees.


Should I buy INVIVYD INC (IVVD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INVIVYD INC (IVVD) stock pay dividends?

IVVD does not pay a dividend.


When does INVIVYD INC (IVVD) report earnings?

INVIVYD INC (IVVD) will report earnings on 2025-03-26, after the market close.


What is the Price/Earnings (PE) ratio of INVIVYD INC (IVVD)?

INVIVYD INC (IVVD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.96).


What is the Short Interest ratio of INVIVYD INC (IVVD) stock?

The outstanding short interest for INVIVYD INC (IVVD) is 6.88% of its float. Check the ownership tab for more information on the IVVD short interest.


IVVD Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to IVVD. When comparing the yearly performance of all stocks, IVVD turns out to be only a medium performer in the overall market: it outperformed 41.95% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IVVD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IVVD. The financial health of IVVD is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IVVD Financial Highlights

Over the last trailing twelve months IVVD reported a non-GAAP Earnings per Share(EPS) of -1.96. The EPS decreased by -41.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -139.04%
ROE -270.72%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-41.67%
Sales Q2Q%N/A
EPS 1Y (TTM)-41.01%
Revenue 1Y (TTM)N/A

IVVD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to IVVD. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst Owners78.39%
Ins Owners0.01%
Short Float %6.88%
Short Ratio0.4
Analysts
Analysts80
Price Target6.01 (396.69%)
EPS Next Y16.6%
Revenue Next YearN/A